Which has the lower trailing P/E, BMY or MCK?

BMY has the lower trailing P/E: BMY trades at 14.89 and MCK at 22.84. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, BMY or MCK?

Over the past five years, MCK grew revenue faster — BMY at a 2.08% CAGR versus MCK at 10.88%.

Does BMY or MCK pay a bigger dividend?

BMY yields 3.71% and MCK yields 0.38% based on trailing dividends and the latest price.

Is BMY or MCK more profitable?

BMY runs the higher net margin — BMY at 18.87% versus MCK at 1.12%.

How have BMY and MCK total returns compared?

Over the past 10 years, BMY delivered 4.96% and MCK delivered 16.88% annualized total return. Past performance doesn't predict future results.

Bristol-Myers Squibb Company (BMY) vs McKesson Corporation (MCK)

A side-by-side comparison of Bristol-Myers Squibb Company and McKesson Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 20, 2026. Differences are shown without an overall score or investment verdict.

BMY

Bristol-Myers Squibb Company

$138.11B

$67.61HealthcareDelayed quote: Aug 19, 2026, 4:00 PM EDT

MCK

McKesson Corporation

$99.95B

$853.71HealthcareAt close: Aug 19, 2026, 4:00 PM ET

Total return — BMY vs MCK

growth of $100 · dividends reinvested · last 10y

BMY +63.7% (+5.1%/yr)MCK +404.3% (+17.6%/yr)MCK compounded faster over this window

BMY MCK

BMY vs MCK: by the numbers

•BMY is the larger company ($138.11B vs $99.95B market cap).
•BMY trades at the lower trailing earnings multiple (14.89 vs 22.84 P/E), one valuation lens rather than an overall verdict.
•BMY converts more revenue to profit (18.87% vs 1.12% net margin).
•MCK grew revenue faster over the past five years (10.88% vs 2.08% CAGR).
•BMY pays the higher dividend yield (3.71% vs 0.38%).

Metrics side by side

Valuation

Metric	BMY	MCK
P/E ratio	14.89	22.84
Forward P/E	10.03	21.88
P/S ratio	2.82	0.25
P/B ratio	6.20	N/A
EV / EBITDA	10.21	14.59
FCF yield	8.26%	6.52%

Profitability

Metric	BMY	MCK
Gross margin	70.16%	3.64%
Operating margin	28.27%	1.62%
Net margin	18.87%	1.12%
ROE	41.59%	-219.24%
ROIC	15.47%	28.34%

Dividends

Metric	BMY	MCK
Dividend yield	3.71%	0.38%
Payout ratio	72.54%	8.51%

Growth (annualized)

Metric	BMY	MCK
Revenue CAGR (5Y)	2.08%	10.88%
EPS CAGR (5Y)	9.38%	40.71%
FCF CAGR (5Y)	-0.95%	14.99%
Total return CAGR (5Y)	3.91%	34.51%

Frequently asked

Which has the lower trailing P/E, BMY or MCK?: BMY has the lower trailing P/E: BMY trades at 14.89 and MCK at 22.84. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, BMY or MCK?: Over the past five years, MCK grew revenue faster — BMY at a 2.08% CAGR versus MCK at 10.88%.
Does BMY or MCK pay a bigger dividend?: BMY yields 3.71% and MCK yields 0.38% based on trailing dividends and the latest price.
Is BMY or MCK more profitable?: BMY runs the higher net margin — BMY at 18.87% versus MCK at 1.12%.
How have BMY and MCK total returns compared?: Over the past 10 years, BMY delivered 4.96% and MCK delivered 16.88% annualized total return. Past performance doesn't predict future results.

Go deeper

Full BMY analysis Full MCK analysis Interactive comparison tool

Dig into the metrics

Bristol-Myers Squibb P/E ratio McKesson P/E ratio Bristol-Myers Squibb dividend yield McKesson dividend yield Bristol-Myers Squibb ROE McKesson ROE Bristol-Myers Squibb operating margin McKesson operating margin Bristol-Myers Squibb revenue growth McKesson revenue growth Bristol-Myers Squibb free cash flow McKesson free cash flow

Bristol-Myers Squibb & McKesson appear in these rankings

Highest Dividend Yield Stocks Highest ROE Stocks Highest ROIC Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 20, 2026.